LCI Learning

Share on Facebook

Share on Twitter

Share on LinkedIn

Share on Email

Share More

LecTec Corporation (OTCBB: LECT) announced today that it has filed a Complaint for patent infringement against Chattem, Inc., Endo Pharmaceuticals, Inc., Johnson & Johnson Consumer Company, Inc., The Mentholatum Company, Inc. and Prince of Peace Enterprises, Inc. in the U.S. District Court for the Eastern District of Texas. The Complaint alleges, among other things, that the defendants have infringed two of LecTec's patents relating to its medicated patch technology. LecTec is seeking to enjoin the defendants from infringing the two patents and to recover monetary damages relating to such infringement, as well as interest and litigation costs. About LecTec Corporation LecTec Corporation is an intellectual property licensing and holding company. The Company's primary focus is to derive royalty and other income from patents that the Company owns based on its advanced skin interface technologies. The Company was an innovator in hydrogel-based topical delivery of therapeutic over-the-counter medications, which provide alternatives to topical creams and ointments. A hydrogel is a gel-like material having an affinity for water and similar compounds. These gels are ideal for delivering medication onto the skin. The Company holds multiple domestic and international patents on its hydrogel technology. By Ms.Bobby Aanand, Metropolitan Jury.
"Loved reading this piece by Ms. Bobby Anand?
Join LAWyersClubIndia's network for daily News Updates, Judgment Summaries, Articles, Forum Threads, Online Law Courses, and MUCH MORE!!"




  Views  251  Report



Comments
img